Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.

Importance Laparoscopic distal gastrectomy and neoadjuvant chemotherapy are increasingly used to treat locally advanced gastric cancer. However, the safety and efficacy of the laparoscopic procedure after neoadjuvant chemotherapy remain unclear. Objective To evaluate the short-term outcomes of patients with locally advanced gastric cancer who received either laparoscopic distal gastrectomy or open distal gastrectomy. Design, Setting, and Participants Between April 23, 2015, and November 16, 2017, a phase 2, open-label, noninferiority randomized clinical trial was conducted at the Gastrointestinal Cancer Center of Peking University Cancer Hospital and Institute in Beijing, China. Patients (n = 96) between 18 and 80 years of age with locally advanced gastric cancer (cT2-4aN+M0) who were receiving neoadjuvant chemotherapy were enrolled and randomized. An as-treated population and a modified intention-to-treat (mITT) population were defined for the data analysis. Interventions Patients were randomized to undergo either laparoscopy-assisted distal gastrectomy (LADG) with D2 lymphadenectomy or open distal gastrectomy (ODG) with D2 lymphadenectomy. Main Outcomes and Measures The primary end point was 3-year recurrence-free survival rate. Secondary end points were surgical radicality, 30-day postoperative morbidity and mortality, 2-week postoperative recovery indexes, and adjuvant chemotherapy completion status. Results In total, 95 patients were eligible for as-treated analyses (LADG: 45, of whom 13 were female [29%], with a median [interquartile range (IQR)] age of 59 [52-65] years; ODG: 50, of whom 16 were female [32%], with a median [IQR] age of 61 [55-64] years) and mITT analyses (LADG: 47, of whom 14 were female [30%], with a median [IQR] age of 59 [52-65] years; ODG: 48, of whom 15 were female [31%], with a median [IQR] age of 61 [55-64] years). In the as-treated analyses, the LADG group had a significantly lower postoperative complication rate than the ODG group (20% vs 46%; P = .007). The postoperative visual analog scale score for pain was 1.2 units lower on postoperative day 2 only in the LADG group (95% CI, -2.1 to -0.3; P = .008). Patients in the LADG group had better adjuvant chemotherapy completion (adjusted odds ratio, 4.39; 95% CI, 1.63-11.80; P = .003) and were less likely to terminate adjuvant chemotherapy because of adverse effects (10 [22%] vs 21 [42%]; P = .04). The mITT analyses showed similar results to as-treated analyses. Conclusions and Relevance This trial found that LADG appears to offer the benefits of better postoperative safety and adjuvant chemotherapy tolerance compared with ODG for patients with locally advanced gastric cancer who received neoadjuvant chemotherapy. Trial Registration ClinicalTrials.gov identifier: NCT02404753.

[1]  W. Rogers,et al.  No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations , 2019, Annals of surgery.

[2]  Yao Wei,et al.  Laparoscopic versus open gastrectomy for advanced gastric cancer: A meta-analysis based on high-quality retrospective studies and clinical randomized trials. , 2018, Clinics and research in hepatology and gastroenterology.

[3]  J. Ji,et al.  Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trial , 2018, Surgical Endoscopy.

[4]  J. Ji,et al.  Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial , 2018, BMJ Open.

[5]  S. Cascinu,et al.  Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. , 2018, International journal of surgery.

[6]  T. Yoshikawa,et al.  Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912 , 2017, Gastric Cancer.

[7]  G. Caldito,et al.  Laparoscopic colectomy for cancer: Improved compliance with guidelines for chemotherapy and survival , 2017, Surgery.

[8]  Hong Xia,et al.  Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer , 2017, Medicine.

[9]  T. Sano Gastric cancer: Asia and the world , 2017, Gastric Cancer.

[10]  Gang Zhao,et al.  Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2014 (ver. 4) , 2016, Gastric Cancer.

[12]  J. Ji,et al.  Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results , 2016, Surgical Endoscopy.

[13]  J. Ji,et al.  A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer , 2015, Medical Oncology.

[14]  Kazuhiro Yoshida,et al.  A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901) , 2015, World Journal of Surgery.

[15]  J. Cheong,et al.  Surgical Complications in Gastric Cancer Patients Preoperatively Treated with Chemotherapy: Their Risk Factors and Clinical Relevance , 2012, Annals of Surgical Oncology.

[16]  C. S. Zhang,et al.  A Prospective Randomized Study Comparing Open versus Laparoscopy-Assisted D2 Radical Gastrectomy in Advanced Gastric Cancer , 2011, Digestive Surgery.

[17]  Augusto Caraceni,et al.  Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. , 2011, Journal of pain and symptom management.

[18]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[19]  Cristiano G S Huscher,et al.  Laparoscopic Versus Open Subtotal Gastrectomy for Distal Gastric Cancer: Five-Year Results of a Randomized Prospective Trial , 2005, Annals of surgery.

[20]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.

[21]  J. Sanabria,et al.  Proposed classification of complications of surgery with examples of utility in cholecystectomy. , 1992, Surgery.

[22]  W. Downie,et al.  Studies with pain rating scales. , 1978, Annals of the rheumatic diseases.

[23]  D. Park,et al.  Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01). , 2016, Annals of surgery.

[24]  Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition , 2011, Gastric Cancer.

[25]  R. Labianca,et al.  Gastric cancer. , 2005, Critical reviews in oncology/hematology.